Epsolay approved by the FDA for rosacea

Galderma has announced that Epsolay has been approved by the FDA for treating rosacea. Epsolay is a proprietary cream formulation of benzoyl peroxide, 5%, designated for the treatment of inflammatory lesions of rosacea in adults. In July 2021 Galderma announced an exclusive 5 year deal to market Epsolay in the US. The creators of Epsolay […]

Epsolay gets boost from Galderma deal

The yet to be approved `encapsulated’ Benzoyl Peroxide 5% Cream known as Epsolay has received a huge promotional boost after the rosacea heavyweight Galderma announced a 5 year exclusive license for the US market. Having the backing of a significant licensing deal from Galderma behind them is good news for the owners of Epsolay. The […]

Epsolay is on its way, will it stay?

The benzoyl peroxide based Epsolay is one step closer to becoming a new treatment for the papules and pustules of rosacea. Based on an active ingredient of 5% bezoyl peroxide, and encapsulating inside silica, the new cream has continued to be tested and now Phase 3 results have been published. So what do the Phase […]

Epsolay is Sol-Gel’s Benzoyl Peroxide for Rosacea

A new treatment for the papules and pustules of rosacea has been given its product name. Publicity surrounding the trial of the new benzoyl peroxide based rosacea topical has mentioned that the product is to be called Epsolay. Previously Epsolay has been known as VERED, S5G4T-1 and DER 45 EV. It is encouraging that Epsolay has […]

Sol-Gel’s S5G4T-1 (Epsolay) benzoyl peroxide cream for papules and pustules

Described in the official trial only as a “topical cream”, Sol-Gel are undergoing a Phase 3 trial for a product newly designated as S5G4T-1. What is S5G4T-1? (Now Epsolay) Although the clinical trial listing doesn’t provide any details about the components of S5G4T-1, their own web site reveals more information. Based on Sol-Gel’s product portfolio, it seems […]